Delivery Order SPE2DB25D3202-SPE2DB25FTBGY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Creon DR 36,000 unit capsules in quantities of 100s, with a ceiling value of $12,946.57. This firm fixed-price delivery order, which is due for completion by July 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation, and performance...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $59,616.66 to AmerisourceBergen Drug Corp for the supply of Creon DR 36,000 Unit Capsules in quantities of 100s. This firm fixed-price delivery order, issued on September 8, 2025, represents a non-set-aside competitive award with an ultimate completion date of September 9, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of 36,000 units of Creon DR 100s capsules, valued at $6,150.38. This competitively awarded, firm fixed-price delivery order is set to be completed by July 30, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,406.80 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s, with performance at the contractor's facility in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and represents a non-set-aside competitive award. The contract was issued on July 30, 2025, under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of 36,000 units of Creon DR 100s capsules, with a ceiling value of $11,594.70. This competitive award, issued with firm fixed-price pricing and no set-aside designation, is fulfilled from the company's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This delivery order is a child contract under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count bottles, valued at $31,396.02. This firm fixed price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX, valued at $999,999,999.00 through December 2026), was competitively awarded with no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Creon DR 36,000 Unit Capsules in packages of 100 units. This competitive, non-set-aside contract is valued at $1,290.59 with firm fixed pricing and a completion date of August 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in Conshohocken, PA...
- The Defense Logistics Agency awarded a delivery order valued at $5,187.93 to AmerisourceBergen Drug Corp for 24,000 unit capsules of Creon DR 100s on September 17, 2025, with an ultimate completion date of September 18, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this delivery order from its corporate office location. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Creon DR 36,000 Unit Capsules in quantities of 100s, valued at $1,956.09. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a non-set-aside competitive award to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $6,901.55 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply support to federal medical systems. The delivery will be performed at the company's corporate office location in...
- SPE2DB25D3202Indefinite Delivery Contract
- SPE2DB25D3202-SPE2DB25FTBGYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (100s) on September 5, 2025, with a ceiling value of $3,179.78 and an ultimate completion date of September 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a comprehensive range of pharmaceutical products and medical commodities to support federal military and veteran healthcare systems. The SPE2DX prime IDC serves as a global pharmaceutical support vehicle enabling the company to deliver pharmaceutical products, specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. Through this contract vehicle, AmerisourceBergen provides critical pharmaceutical support to customers including the Defense Health Agency and U.S. Coast Guard, with DLA Troop Support planning future Pharmaceutical Prime Vendor Global Program Generation V contracts that may involve multiple regional awards among different contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 9/5/25 |